Examples of Proteomic Screens Executed at HOC

  • Q Li Zhen, et al., Identification of autoantibody clusters that best predict lupus disease activity using glomerular proteome arrays. J Clin Invest 2005; 115:3428-3439. PubMed PMID: 16322790
  • Stanley S, et al., Identification of Low-Abundance Urinary Biomarkers in Lupus Nephritis Using Electrochemiluminescence Immunoassays. Arthritis Rheumatol. 2019 May;71(5):744-755. doi: 10.1002/art.40813. Epub 2019 Apr 3. PubMed PMID:30618193
  • Parodis I, et al., ALCAM and VCAM-1 as urine biomarkers of activity and long-term renal outcome in systemic lupus erythematosus. Rheumatology (Oxford). 2019 Nov 1;. doi: 10.1093/rheumatology/kez528. PubMed PMID: 317224193
  • Vanarsa K, et al., Quantitative planar array screen of 1000 proteins uncovers novel urinary protein biomarkers of lupus nephritis. Ann Rheum Dis. 2020 Jul 10;. doi: 10.1136/annrheumdis-2019-216312doi: 10.1136/annrheumdis-2019-216312. PubMed PMID: 32651195
  • S Stanley, et al., Novel Urinary Biomarkers of Lupus Nephritis from comprehensive Aptamer-based Screening of 1129 Proteins. Nature Communication 2020:11(1):2197.doi: 10.1038/s41467-020-15986-3. Nature Communications Article ID: s41467-020-15986-3 
  • Fava A, et al., Integrated urine proteomics and renal single-cell genomics identify an Interferon-γ response gradient in lupus nephritis. JCI Insight. 2020 May 12: 138345. doi: 10.1172/jci.insight.138345. PubMed PMID: 32396533